James Lin

Cooley advised Apollo Endosurgery, a medical device company, on its agreement to be acquired by Boston Scientific in an all-cash transaction with an enterprise value of approximately $615 million.

Cooley advised Inscripta, a global leader in genome engineering technology, on its acquisition of Infinome Biosciences and Sestina Bio. These acquisitions advance Inscripta’s strategy to develop and commercialize biomanufactured products for a broad spectrum of industrial and consumer markets. They also demonstrate Inscripta’s confidence in the commercial potential of the bioeconomy and the power of genome engineering to accelerate biomanufacturing innovation. Partner Mike Nelson led the Cooley team.

Cooley advised Nutrafol, a leading provider of hair wellness products, on its agreement to sell a majority stake in the company to Unilever. Partner Kevin Cooper led the Cooley team advising Nutrafol on the transaction, and partner Stephane Levy has acted as longtime corporate counsel to the company. Nutrafol is backed by Unilever Ventures and consumer-focused private equity firm L Catterton.

Cooley advised PatientPop, a medical practice growth technology platform, on its agreement to merge with cloud-based clinical and financial software company Kareo to form Tebra. Lawyers Nick Hobson, David Silverman, Steven Dunst and Izzy Lubarsky led the Cooley team advising PatientPop.